Hikma appoints Robert Pickering to board
This article was originally published in Scrip
Executive Summary
Generics developer Hikma Pharmaceuticals has named Robert Pickering an independent non-executive director effective 1 September. Mr Pickering retired in 2008, having spent 23 years at Cazenove & Co., becoming the first CEO of Cazenove Group in 2001, and also serving as CEO of JP Morgan Cazenove, a joint venture partnership.